The comparative effectiveness of natalizumab and ocrelizumab in naive relapsing remitting multiple sclerosis: the impact on relapse dependent and relapse independent disability progression

被引：0

作者：

Iaffaldano, Pietro ^{[1
]}

Lucisano, Giuseppe ^{[2
]}

Guerra, Tommaso ^{[1
]}

Paolicelli, Damiano ^{[1
]}

Inglese, Matilde ^{[3
,4
]}

Foschi, Matteo ^{[5
]}

Patti, Francesco ^{[6
,7
]}

Granella, Franco ^{[8
]}

Romano, Silvia ^{[9
]}

Cavalla, Paola ^{[10
]}

De Luca, Giovanna ^{[11
]}

Gallo, Paolo ^{[12
]}

Bellantonio, Paolo ^{[13
]}

Gallo, Antonio ^{[14
]}

Montepietra, Sara ^{[15
]}

Di Sapio, Alessia ^{[16
]}

Vianello, Marika ^{[17
]}

Quatrale, Rocco ^{[18
]}

Spitaleri, Daniele ^{[19
]}

Clerici, Raffaella ^{[20
]}

Clerici, Valentina Torri ^{[21
]}

Cocco, Eleonora ^{[22
]}

Morra, Vincenzo Brescia ^{[23
]}

Marfia, Girolama Alessandra ^{[24
]}

Filippi, Massimo ^{[25
,26
]}

Amato, Maria Pia ^{[27
]}

Trojano, Maria ^{[1
]}

机构：

[1] Univ Bari Aldo Moro, Dept Translat Biomed & Neurosci DiBraiN, Bari, Italy

[2] CORESEARCH Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy

[3] Univ Genoa, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, Genoa, Italy

[4] Osped Policlin San Martino, IRCCS, Genoa, Italy

[5] S Maria delle Croci Hosp Ravenna, Dept Neurosci, Multiple Sclerosis Ctr, Neurol Unit,AUSL Romagna, Ravenna, Italy

[6] GF Ingrassia, Dipartimento Sci Med & Chirurg & Tecnol Avanzate, Ctr Sclerosi Multipla, Sez Neurosci, Catania, Italy

[7] Univ Catania, Catania, Italy

[8] Univ Parma, Dept Med & Surg, Unit Neurosci, Parma, Italy

[9] Sapienza Univ Rome, SantAndrea Hosp, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy

[10] AOU Citta Salute & Sci Torino, Dept Neurosci & Mental Hlth, Via Cherasco 15, I-10126 Turin, Italy

[11] Policlin SS Annunziata, Clin Neurol, Ctr Sclerosi Multipla, Chieti, Italy

[12] Univ Hosp Padua, Multiple Sclerosis Ctr Veneto Reg CeSMuV, Dept Neurosci, Padua, Italy

[13] IRCCS Neuromed, Unit Neurol & Neurorehabil, Pozzilli, Italy

[14] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy

[15] AUSL IRCCS Reggio Emilia, Neuromotor & Rehabil Dept, Neurol Unit, Reggio Emilia, Italy

[16] Univ Hosp San Luigi, Neurol Unit, Reg Referral MS Ctr, Orbassano, Italy

[17] Ca Foncello Hosp, Unit Neurol, Treviso, Italy

[18] Osped Angelo, Div Neurol, Ambulatorio Sclerosi Multipla, Venice, Italy

[19] AORN San G Moscati Avellino, Dept Neurol, Avellino, Italy

[20] Osped Gen Zona Valduce, Ctr Alta Specializzaz Diag & Cura Sclerosi Multip, Como, Italy

[21] Fdn Neurol Inst C Besta, Milan, Italy

[22] Univ Cagliari, Dept Med Sci & Publ Hlth, Ctr Sclerosi Multipla, Cagliari, Italy

[23] Univ Naples Federico II, Dept Neurosci NSRO, Multiple Sclerosis Clin Care & Res Ctr, Naples, Italy

[24] Univ Hosp Rome Tor Vergata, Multiple Sclerosis Clin & Res Unit, Rome, Italy

[25] Univ Vita Salute San Raffaele, MS Ctr, Neurol Unit, Neurorehabil Unit,Neurophysiol Unit, Milan, Italy

[26] Ist Sci San Raffaele, Milan, Italy

[27] Univ Florence, Dept NEUROFARBA, Florence, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P326/1343

引用

页码：368 / 369

页数：2

共 50 条

[1] Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis
Kappos, L.
Wolinsky, J. S.
Giovannoni, G.
Arnold, D. L.
Lublin, F.
Wang, Q.
Model, F.
Wei, W.
Garren, H.
Manfrini, M.
Belachew, S.
Hauser, S. L.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 309 - 310
[2] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Cavit Boz
Serkan Ozakbas
Murat Terzi
Rana Karabudak
Serhan Sevim
Recai Turkoglu
Aysun Soysal
Belgin Petek Balcı
Hüsnü Efendi
Ömer Faruk Turan
Nur Yüceyar
Mehmet Fatih Yetkin
Serap Zengin Karahan
Meltem Demirkıran
Sibel Guler
Kadriye Agan
Nefati Kıylıoğlu
Cavid Baba
Asli Tuncer
Mesrure Köseoğlu
Neurological Sciences, 2023, 44 : 2121 - 2129
[3] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Boz, Cavit
Ozakbas, Serkan
Terzi, Murat
Karabudak, Rana
Sevim, Serhan
Turkoglu, Recai
Soysal, Aysun
Balci, Belgin Petek
Efendi, Husnu
Turan, Omer Faruk
Yuceyar, Nur
Yetkin, Mehmet Fatih
Karahan, Serap Zengin
Demirkiran, Meltem
Guler, Sibel
Agan, Kadriye
Kiylioglu, Nefati
Baba, Cavid
Tuncer, Asli
Koseoglu, Mesrure
NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
[4] OCRELIZUMAB REDUCES DISABILITY PROGRESSION INDEPENDENT OF RELAPSE ACTIVITY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS (RMS) (ENCORE)
Kappos, Ludwig
Wolinsky, Jerry S.
Giovannoni, Gavin
Arnold, Douglas L.
Lublin, Fred
Wang, Qing
Model, Fabian
Wei, Wei
Garren, Hideki
Manfrini, Marianna
Belachew, Shibeshih
Hauser, Stephen
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E25 - E25
[5] Relapse-independent multiple sclerosis progression under natalizumab
Graf, Jonas
Leussink, Verena, I
Soncin, Giulia
Lepka, Klaudia
Meinl, Ingrid
Kumpfel, Tania
Meuth, Sven G.
Hartung, Hans-Peter
Havla, Joachim
Aktas, Orhan
Albrecht, Philipp
BRAIN COMMUNICATIONS, 2021, 3 (04)
[6] Metabolomics associated with relapse rate and disability progression in relapse remitting multiple sclerosis patients
Kitsos, D.
Sideri, E.
Chondrogianni, M.
Tsivgoulis, A.
Zompola, C.
Thomaidis, N.
Voumvourakis, K.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 938 - 938
[7] Progression independent of relapse activity drives permanent disability accrual in relapsing multiple sclerosis
Betti, M.
Portaccio, E.
De Meo, E.
Pasto, L.
Razzolini, L.
Totaro, R.
Spitaleri, D.
Lugaresi, A.
Cocco, E.
Onofri, M.
Patti, F.
Maimone, D.
Confalonieri, P.
Ferraro, D.
Maniscalco, G.
Morra, V. Brescia
Granella, F.
Pesci, I.
Bergamaschi, R.
Simone, M.
Lepore, V.
Iaffaldano, P.
Filippi, M.
Trojano, M.
Amato, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 417 - 418
[8] Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis
Montalban, Xavier
Cohen, Jeffrey A.
Comi, Giancarlo
Coyle, Patricia K.
Kappos, Ludwig
Li, Bingbing
Sfikas, Nikolaos
Willi, Roman
Haring, Dieter A.
Merschhemke, Martin
Hauser, Stephen L.
NEUROLOGY, 2020, 94 (15)
[9] Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis
Kappos, Ludwig
Montalban, Xavier
Coyle, Patricia
Nicholas, Jacqueline
Meuth, Sven
Li, Bingbing
Ramanathan, Krishnan
Su, Wendy
Willi, Roman
Haering, Dieter A.
Hauser, Stephen
NEUROLOGY, 2021, 96 (15)
[10] Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Portaccio, Emilio
Betti, Matteo
De Meo, Ermelinda
Addazio, Ilaria
Pasto, Luisa
Razzolini, Lorenzo
Totaro, Rocco
Spitaleri, Daniele
Lugaresi, Alessandra
Cocco, Eleonora
Onofrj, Marco
Di Palma, Franco
Patti, Francesco
Maimone, Davide
Valentino, Paola
Clerici, Valentina Torri
Protti, Alessandra
Ferraro, Diana
Lus, Giacomo
Maniscalco, Giorgia Teresa
Morra, Vincenzo Brescia
Salemi, Giuseppe
Granella, Franco
Pesci, Ilaria
Bergamaschi, Roberto
Aguglia, Umberto
Vianello, Marika
Simone, Marta
Lepore, Vito
Iaffaldano, Pietro
Comi, Giancarlo
Filippi, Massimo
Trojano, Maria
Amato, Maria Pia
JOURNAL OF NEUROLOGY, 2024, 271 (08) : 5074 - 5082

← 1 2 3 4 5 →